Millennium Management’s Mustang Bio MBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-372
Closed -$102K 6467
2023
Q1
$102K Buy
372
+50
+16% +$20.5K ﹤0.01% 5424
2022
Q4
$95K Sell
322
-96
-23% -$32.8K ﹤0.01% 5598
2022
Q3
$147K Sell
418
-440
-51% -$204K ﹤0.01% 5817
2022
Q2
$376K Buy
858
+836
+3,800% +$463K ﹤0.01% 5185
2022
Q1
$16K Sell
22
-816
-97% -$670K ﹤0.01% 6673
2021
Q4
$1.04M Sell
838
-34
-4% -$54.9K ﹤0.01% 4368
2021
Q3
$1.76M Buy
872
+5
+0.6% +$10.7K ﹤0.01% 4070
2021
Q2
$2.16M Sell
867
-814
-48% -$2M ﹤0.01% 3867
2021
Q1
$4.19M Sell
1,681
-854
-34% -$2.54M ﹤0.01% 2773
2020
Q4
$7.2M Buy
2,535
+602
+31% +$1.44M 0.01% 2099
2020
Q3
$4.57K Buy
1,933
+875
+83% +$2.16M 0.01% 1929
2020
Q2
$2.52M Buy
1,058
+1,017
+2,480% +$2.38M ﹤0.01% 2359
2020
Q1
$83K Buy
41
+25
+156% +$64.1K ﹤0.01% 3584
2019
Q4
$48K Sell
16
-23
-59% -$52.7K ﹤0.01% 4100
2019
Q3
$95K Buy
+39
New +$107K ﹤0.01% 3976
2018
Q2
Sell
-135
Closed -$1.1M 4018
2018
Q1
$1.1M Buy
135
+99
+275% +$843K ﹤0.01% 2639
2017
Q4
$326K Buy
+36
New +$279K ﹤0.01% 3310

Other funds holding MBIO

Millennium Management's MBIO Position: Q2 2023 in Review

Millennium Management sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 372 shares — an estimated $102K sold.

Millennium Management first reported a position in MBIO in Q4 2017 and held it in 17 quarters. The position peaked at $7.2M in Q4 2020. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Millennium Management reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
  • Millennium Management sold 372 Mustang Bio shares in Q2 2023, an estimated $102K.
  • Millennium Management first reported a position in Mustang Bio in Q4 2017 and held it in 17 quarters.
  • Millennium Management's Mustang Bio position peaked at $7.2M in Q4 2020.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.